|
|||||
|
|
Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy |
|
| Authors: | Madeline M. Cook Luai Al Rabadi Andy J. Kaempf Megan M. Saraceni Michael A. Savin Zahi I. Mitri |
| Affiliation: | 1. Oregon Health & Science University, Portland, Oregon, USA;2. Department of Hematology Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon, USA;3. Knight Cancer Institute Biostatistics Shared Resource, Oregon Health & Science University, Portland, Oregon, USA;4. Department of Pharmacy, Oregon Health & Science University, Portland, Oregon, USA |
| Abstract: | |
| Keywords: | Metastatic hormone receptor-positive breast cancer Everolimus plus exemestane CDK4/6 inhibitors Cohort studies |